Philip Morris International Inc.(PM)Earnings, Financials & Key RatiosPhilip Morris International Inc. (PM) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
while the company maintains a strong 68.1% gross margin, the combination of a 0.98 current ratio and $51.9 billion in total debt warrants caution regarding long-term solvency.
Philip Morris International Inc. (PM) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Philip Morris International Inc. (PM) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 22, 2026 | $1.96vs $1.86+5.4% | $10.1Bvs $10.0B+1.9% |
| Q1 2026 | Feb 6, 2026 | $1.70vs $1.70+0.0% | $10.4Bvs $10.4B-0.4% |
| Q4 2025 | Oct 21, 2025 | $2.24vs $2.09+7.2% | $10.8Bvs $10.6B+2.0% |
| Q3 2025 | Jul 22, 2025 | $1.91vs $1.86+2.7% | $10.1Bvs $10.3B-1.7% |
Recent stock market news and headlines for Philip Morris International Inc. (PM)
Altria maintains strong domestic dominance through its Marlboro brand and generates significant free cash flow from its U.S. operations. Philip Morris International is aggressively expanding its global smoke-free portfolio with brands like IQOS and ZYN in over 100 markets.
Anchor your portfolio with this high-yield Dividend King.
The FDA will allow 20 Philip Morris-owned Zyn nicotine pouch products to carry a modified-risk claim saying switching from cigarettes lowers the risk of several smoking-related diseases. The decision gives Philip Morris a major marketing win for one of the fastest-growing nicotine products as cigarette sales decline in the U.S.
STAMFORD, CT--(BUSINESS WIRE)--Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke,.
Altria maintains a dominant position in the U.S. tobacco market with industry-leading net margins and a massive domestic distribution network. Philip Morris International is leading the global shift to smoke-free products with its Iqos and ZYN platforms across more than 100 markets.
Key metrics vs top competitors for Philip Morris International Inc. (PM)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $187.79 | $292.68B | 25.87 | 7.31% | 27.92% | — | 2.95% | |
| $72.96 | $121.98B | 17.75 | -1.49% | 36.91% | — | — | |
| $61.80 | $133.88B | 13.23 | -0.99% | 21.04% | 21.69% | — | |
| $4.36 | $1.5M | -0.08 | -40.66% | -44.9% | -25.03% | — | |
| $4.75 | $192.85M | 3.89 | 36.55% | -19.55% | -3.39% | — | |
| $51.66 | $1.29B | 39.74 | -0.77% | 1.12% | 2.18% | — |
Philip Morris International Inc. (PM) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Philip Morris International Inc. (PM) SEC filings — annual & quarterly reports (10-K, 10-Q)
Apr 22, 2026·SEC
Mar 13, 2026·SEC
Mar 5, 2026·SEC
Get notified when PM posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Philip Morris International Inc. (PM) stock FAQ — growth, dividends, profitability & financials explained
Philip Morris International Inc. (PM) reported $41.49B in revenue for fiscal year 2025. This represents a 24% increase from $33.39B in 2003.
Philip Morris International Inc. (PM) grew revenue by 7.3% over the past year. This is steady growth.
Yes, Philip Morris International Inc. (PM) is profitable, generating $11.10B in net income for fiscal year 2025 (27.9% net margin).
Yes, Philip Morris International Inc. (PM) pays a dividend with a yield of 2.95%. This makes it attractive for income-focused investors.
Philip Morris International Inc. (PM) generated $10.67B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
